Vivimed Labs (NSE:VIVIMEDLAB) Inventories, Finished Goods: ₹0.0 Mil (As of Dec. 2025)


NSE:VIVIMEDLAB Vivimed Labs Ltd NSE:VIVIMEDLAB
47 GF Score
Price ₹5.70
GF Value ₹2.56
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Vivimed Labs Inventories, Finished Goods?

Vivimed Labs NSE:VIVIMEDLAB -1.55% 47 Inventories, Finished Goods is ₹0.0 Mil as of Dec. 2025. GuruFocus rates NSE:VIVIMEDLAB with a GF Score™ of 47/100 and a GF Value™ of ₹2.56 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Vivimed Labs's annual finished goods declined from Mar. 2023 (₹212.7 Mil) to Mar. 2024 (₹75.8 Mil) but then increased from Mar. 2024 (₹75.8 Mil) to Mar. 2025 (₹107.8 Mil).

Vivimed Labs Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Vivimed Labs's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivimed Labs Inventories, Finished Goods Chart

Vivimed Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 647.65 720.51 212.70 75.77 107.79

Vivimed Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 107.79 0.00 0.00 0.00
NSE:VIVIMEDLAB
47GF Score
Vivimed Labs Ltd NSE:VIVIMEDLAB
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivimed Labs Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of ₹0.0 Mil mean?
Vivimed Labs (NSE:VIVIMEDLAB) has a Inventories, Finished Goods of ₹0.0 Mil as of Dec. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on Vivimed Labs and its competitors.
Is Vivimed Labs' Inventories, Finished Goods too high?
Vivimed Labs' current Inventories, Finished Goods is ₹0.0 Mil. Overall, Vivimed Labs has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vivimed Labs' Inventories, Finished Goods compare to ZTS and UTHR?
Vivimed Labs' Inventories, Finished Goods of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Vivimed Labs and its competitors. Vivimed Labs's current Inventories, Finished Goods is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivimed Labs stock overvalued right now?
Based on GuruFocus' analysis, Vivimed Labs (NSE:VIVIMEDLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.56, compared to a current price of ₹5.70 — trading 122.7% above its estimated fair value. The current Inventories, Finished Goods is ₹0.0 Mil. Vivimed Labs' overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Vivimed Labs (NSE:VIVIMEDLAB), the current Inventories, Finished Goods is ₹0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivimed Labs (NSE:VIVIMEDLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vivimed Labs stock appears to be overvalued. The current stock price of ₹5.70 is trading 122.7% above its estimated GF Value™ of ₹2.56. GuruFocus considers Vivimed Labs to be Significantly Overvalued.

Key valuation signals for NSE:VIVIMEDLAB:

  • Inventories, Finished Goods: ₹0.0 Mil
  • GF Value™: ₹2.56 vs. price of ₹5.70 (122.7% above fair value)
  • GF Score™: 47/100 with 7 warning signs

No single metric tells the full story. See the NSE:VIVIMEDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vivimed Labs Business Description

Other Exchanges 532660:India
Address Green Lands, Beside The Plaza Hotel, D.No. 6-3-866/1/G1, 3rd & 4th Floor, GMR Towers, Begumpet, Hyderabad, TG, IND, 500016
Vivimed Labs Ltd is an India-based company that is engaged in the Business of Active pharmaceutical ingredients, Intermediates, Nutraceutical ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals, and Retail Branded Formulation manufacturing. The company has three reportable segments: the Speciality Chemicals Business, the Pharma Business, and others. The majority of revenue is earned through the Pharma business.
47GF Score

Get the complete analysis for NSE:VIVIMEDLAB

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5.70
Price
₹2.56
GF Value